Glowing dye could help burn surgeons cut away only the dead tissue
NCT ID NCT05593523
First seen Jan 04, 2026 · Last updated Jun 20, 2026 · Updated 22 times
Summary
This study tests whether a fluorescent dye called indocyanine green (ICG) can help surgeons see exactly which parts of a burn wound are dead or inflamed. Up to 100 burn patients will receive the dye and have their wounds imaged with a special camera before and during surgery. The goal is to see if this technique helps surgeons remove only the damaged tissue, which could lead to better healing and fewer surgeries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BURN WOUND are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Indocyanine green (ICG) dye
What this could lead to
If successful, this could lead to a more precise surgical tool to help burn surgeons remove only the dead tissue, potentially improving wound healing and reducing the need for repeat surgeries.
What could go wrong
This is an early-stage study with only 100 participants, focused on measuring imaging accuracy, not on proving better outcomes. The dye and device are already FDA-approved for other uses, but their benefit for burn surgery is not yet established.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.